Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model
Author Information
Author(s): Claire Vanpouille-Box, Franck Lacoeuille, Jérôme Roux, Christophe Aubé, Emmanuel Garcion, Nicolas Lepareur, Frédéric Oberti, Francis Bouchet, Nicolas Noiret, Etienne Garin, Jean-Pierre Benoît, Olivier Couturier, François Hindré
Primary Institution: LUNAM Université, Université d'Angers, INSERM U646, Angers, France
Hypothesis
The study aims to confirm the feasibility and assess the efficacy of internal radiation with lipid nanocapsules loaded with Rhenium-188 in a rat model of hepatocellular carcinoma.
Conclusion
Internal radiation with lipid nanocapsules loaded with Rhenium-188 is a promising new strategy for treating hepatocellular carcinoma.
Supporting Evidence
- Treatment with LNC188Re-SSS increased median survival from 54 to 107% compared to control groups.
- Seven long-term survivors were observed in the LNC188Re-SSS group.
- Decreased vascular endothelial growth factor expression was noted in treated rats.
Takeaway
Researchers found that tiny capsules filled with a radioactive substance can help slow down liver cancer in rats.
Methodology
Rats with chemically induced hepatocellular carcinoma were treated with lipid nanocapsules loaded with Rhenium-188, and their survival and tumor progression were monitored.
Limitations
The study was conducted on a rat model, which may not fully replicate human responses.
Participant Demographics
Male Wistar rats, aged 6 weeks, weighing 150–180 g.
Statistical Information
P-Value
0.0139
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website